Examining the relationship between parents' knowledge and attitudes about the HPV vaccine and the acceptance of injections in girl

سال انتشار: 1401
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 84

متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

WMCONF08_048

تاریخ نمایه سازی: 26 بهمن 1401

چکیده مقاله:

Introduction: The HPV vaccine helps protect you against certain types of HPV that can lead to cancer or genital warts. Most cervical cancers are related to the human papillomavirus (HPV), which is a sexually transmitted infection. Widespread immunization with HPV vaccine can reduce cervical cancer worldwide. Different types of HPV are transmitted through sexual contact and are associated with most cases of cervical cancer. Gardasil ۹ is an HPV vaccine that is approved by the US Food and Drug Administration and can be used for both boys and girls. This vaccine can prevent cervical cancer before a girl or woman is exposed to the virus. In addition, the vaccine can prevent vaginal and vaginal cancer in women and also prevent genital warts and anal cancer in women and men. In theory, vaccinating boys against HPV types associated with cervical cancer may also protect girls from the virus by reducing the chance of passing the virus to girls. Also, certain types of HPV are linked to oral and throat cancers, so the HPV vaccine is likely to protect against these cancers. The HPV vaccine is typically recommended for boys and girls aged ۱۱ or ۱۲, although it may also be given as early as age ۹. It is ideal that girls and boys receive the vaccine before they have sexual contact and before they are exposed to HPV. do Once someone is infected with HPV, the vaccine may not be as effective or may not work. Also, the response to the vaccine is better at a young age than at an older age. The Centers for Disease Control and Prevention (CDC) now recommends that all ۱۱- and ۱۲-year-olds receive two doses of the HPV vaccine at least six months apart. Adolescents and young adults who start receiving vaccines between the ages of ۱۵ and ۲۶ should receive three doses of the vaccine. The FDA recently approved the use of Gardasil ۹ for men and women ages ۹ to ۴۵. The HPV vaccine is not recommended for pregnant women or people who are moderately or severely ill. If a person has already had one type of HPV infection, they can still benefit from the vaccine because it can protect them from other types of HPV that they have not yet had. However, none of the vaccines can cure an existing HPV infection. Vaccines can only protect against certain strains of HPV that a person has not been exposed to before. The effects of the vaccine are usually mild. The most common side effects of HPV vaccines include pain, swelling, or redness at the injection site. Sometimes dizziness or fainting occurs after the injection. Sitting for ۱۵ minutes after the injection can reduce the risk of fainting. In addition, headache, nausea, vomiting, fatigue or weakness may also occur. The HPV vaccine does not replace Pap tests. Routine screening for cervical cancer through regular Pap tests starting at age ۲۱ is an essential part of a woman's preventive health care.

کلیدواژه ها:

Parents' knowledge and attitudes ، HPV ، Gardasil vaccine

نویسندگان

Reihaneh Amini

Department of midwifery, Nursing & Midwifery sciences Development Research Center, Najafabad Branch,Islamic Azad University, Najafabad, Iran.

Soheila Nori

Department of midwifery, Nursing & Midwifery sciences Development Research Center, Najafabad Branch,Islamic Azad University, Najafabad, Iran.

Farahnaz Nori

Department of midwifery, Nursing & Midwifery sciences Development Research Center, Najafabad Branch,Islamic Azad University, Najafabad, Iran.

Nasim khademi

Department of midwifery, Nursing & Midwifery sciences Development Research Center, Najafabad Branch,Islamic Azad University, Najafabad, Iran.